Cytoreduction and Hyperthermic Intraperitoneal Paclitaxel and Cisplatin for Gastric Cancer with Peritoneal Metastasis.
EeeLN BuckarmaCornelius A ThielsZhaohui JinTravis E GrotzPublished in: Annals of surgical oncology (2023)
CRS and HIPEC with paclitaxel and cisplatin is well tolerated and is associated with favorable oncologic and perioperative outcomes.